APA (7th ed.) Citation

SM, K., DA, H., JM, M., JRW, M., Y, B., AM, H., . . . PD, T. (2026). Comparative outcomes of ceftazidime-avibactam versus meropenem-vaborbactam for KPC-producing Enterobacterales infections. Antimicrobial agents and chemotherapy, 70(5), e0160225. https://doi.org/10.1128/aac.01602-25

Chicago Style (17th ed.) Citation

SM, Karaba, et al. "Comparative Outcomes of Ceftazidime-avibactam Versus Meropenem-vaborbactam for KPC-producing Enterobacterales Infections." Antimicrobial Agents and Chemotherapy 70, no. 5 (2026): e0160225. https://doi.org/10.1128/aac.01602-25.

MLA (9th ed.) Citation

SM, Karaba, et al. "Comparative Outcomes of Ceftazidime-avibactam Versus Meropenem-vaborbactam for KPC-producing Enterobacterales Infections." Antimicrobial Agents and Chemotherapy, vol. 70, no. 5, 2026, p. e0160225, https://doi.org/10.1128/aac.01602-25.